5-6: Chronic Inflammation + Treatments Flashcards
What are the three outcomes of acute inflammation?
- Resolution - normal function restored (usually after minimal injury) macrophages clear stimuli, mediators and cells, edema reabsorbed by lymphatic
- Healing - normal function lost; fibrosis (after more substantial tissue damage where regeneration is not possible)
- Progression to CHRONIC INFLAMMATION (usually immune-mediated, persistent infection, hypersensitivity or prolonged exposure to toxic agents)
What are the distinguishing features of Chronic inflammation?
- Slow, prolonged inflammation
- Systematic signs
- Mainly monocytes/macrophages and lymphocytes
- Tissue Injury + Repair (fibrosis + angiogenesis)
- Adaptive immune system involved
What microscopic features of chronic inflammation might be seen in lung tissue?
- Replacement of alveoli with cuboidal-epithelium-lined spaces
- Replacement by connective tissue
Describe the role of macrophages in chronic inflammation
They are the DOMINANT cell type
- Derive from stem cells -> monoblasts -> monocytes -> ENTER TISSUES
- Names: Microglia in brain, osteoclasts in bone, Kupffer cells in liver, alveolar macrophages etc
- Two pathways of activation - classical and alternative:
- Classical -> microbicidal and inflammatory actions
- Alternative -> Tissue repair, fibrosis and anti-inflammatory actions
Describe the “Vicious Cycle” of Leukocyte activation
Classically activated macrophages present antigens to T cells, activating them
-> Release TNF, IL1-17, Chemokines
-> Recruit more macrophages!
Define atherosclerosis
A form of arteriosclerosis in which atheromatous plaques - lesions with a lipid core and white fibrous cap - make the arteries stiff
Describe the four groups of risk factors for atherosclerosis
- Modifiable (e.g., hypertension, LDL levels, smoking/obesity/diabetes)
- Non-modifiable (e.g., age, sex, genetic predisposition)
- Inflammatory (e.g., CRP, ILs, Adhesion Molecules, Coagulation Factors)
- Other (e.g., insulin resistance, hyperhomocysteinaemia)
What are the differences observed in an endothelial cell in Endothelial Dysfunction?
Instead of a non-adhesive, non-thrombogenic surface:
- Increased procoagulent expression
- Increased adhesion molecule expression
- Chemokine, Cytokine and GFs expression
What factors mediate the migration of leukocytes through the vascular endothelium in plaque formation?
- Increased permeability (mediated by NO, PGL2, etc)
- Chemokines (MCP-1 from Monocytes, CCL5 and CXCL4 from platelets)
- Leukocyte adhesion (esp. monocytes and T cells - due to upregulation of adhesion mol’s e.g. VCAM-1, IAM-1, selectins)
What three changes can be seen in endothelium during plaque formation BESIDES leukocyte adhesion?
- VSM aggregation (stimulated by PDGF, FGF2 and TGF-ß)
- Platelets (stimulated by integrins, P-selectin, fibrin, TXA2)
- Fatty streaks (as macrophages and VSM cells engulf lipids)
What are the treatment options for Atherosclerosis?
- NON-Pharmacological (e.g., diet, exercise, quit smoking, less alcohol)
- Lipid-lowering drugs that either:
- inhibit cholesterol absorption (bile and binding resins)
- reduce cholesterol synthesis (statins e.g. simvastatin, atorvastatin)
- promote cholesterol metabolism (fibrates e.g. bezafibrate - these reduce VLDL, LDL-C, triglycerides and increase HDL-C)
What is the key, rate limiting step in cholesterol synthesis that is targeted by statins?
Conversion of HMG-CoA to mevalonic acid by HMG-CoA reductase
How does targeting cholesterol synthesis in the liver affect plasma LDL?
Less cholesterol synthesis -> upregulated LDL receptor expression -> more LDLs cleared from blood into cells -> lower plasma LDL
What anti-inflammatory actions do statins have?
- Supress platelet activation
- Stabilise plaque to prevent rupture (reduced Matrix Metalloproteases so less collagen breakdown)
- Inhibit proliferation and migration of VSM cells
- Reduce production of cytokines by reducing TLR2/4 receptors
- Upregulate IL-10
What are the 5 (mentioned) groups of anti-inflammatory drugs?
- Antihistamines
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Steroidal Anti-Inflammatory Drugs
- Disease-modifying Anti-Rheumatic Drugs (DMARDs)
- Anti-cytokines